Infirmary Cancer Center

Mobile, Alabama 36607

0 studies enrolling now · 1 studies all time

What they study most

Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer

Studies at this site

• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling